Patents by Inventor Xiaofang Bian

Xiaofang Bian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for diagnosis of type 1 diabetes
    Patent number: 11567088
    Abstract: Type 1 diabetes (T1D) patients make antibodies to self-proteins that are potential biomarkers for early detection and risk prediction. We have identified seventeen antigens as biomarkers for early diagnosis and risk prediction of T1D, including the antigens MLH1, MTIF3, PPIL2, NUP50, TOX4, FIGN, C9orf142, ZNF280D, HES1, QRFPR, CTRC, SNX6, SYTL4, ELA2A, IGRP, PAX6, and HMGN3.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: January 31, 2023
    Assignees: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY, UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INC.
    Inventors: Joshua LaBaer, Ji Qiu, Xiaofang Bian, Desmond A. Schatz, Clive H. Wasserfall, Mark A. Atkinson
  • Type 1 Diabetes Biomarkers
    Publication number: 20200182887
    Abstract: Type 1 diabetes (T1D) patients make antibodies to self-proteins that are potential biomarkers for early detection and risk prediction. We have identified seventeen antigens as biomarkers for early diagnosis and risk prediction of T1D, including the antigens MLH1, MTIF3, PPIL2, NUP50, TOX4, FIGN, C9orf142, ZNF280D, HES1, QRFPR, CTRC, SNX6, SYTL4, ELA2A, IGRP, PAX6, and HMGN3.
    Type: Application
    Filed: February 14, 2020
    Publication date: June 11, 2020
    Applicants: Arizona Board of Regents on behalf of Arizona State University, University of Florida Research Foundation, Incorporated
    Inventors: Joshua LaBaer, Ji Qiu, Xiaofang Bian, Desmond A. Schatz, Clive H. Wasserfall, Mark A. Atkinson
  • Type 1 Diabetes Biomarkers
    Publication number: 20160195546
    Abstract: Type 1 diabetes (T1D) patients make antibodies to self-proteins that are potential biomarkers for early detection and risk prediction. We have identified seventeen antigens as biomarkers for early diagnosis and risk prediction of T1D, including the antigens MLH1, MTIF3, PPIL2, NUP50, TOX4, FIGN, C9orf142, ZNF280D, HES1, QRFPR, CTRC, SNX6, SYTL4, ELA2A, IGRP, PAX6, and HMGN3.
    Type: Application
    Filed: January 7, 2016
    Publication date: July 7, 2016
    Applicants: Arizona Board of Regents on behalf of Arizona State University, University of Florida Research Foundation, Incorporated
    Inventors: Joshua LaBaer, Ji Qiu, Xiaofang Bian, Desmond A. Schatz, Clive H. Wasserfall, Mark A. Atkinson